The best indicator for Zoetis (ZTS)
We backtested 366 indicators across daily, weekly and hourly charts on real Zoetis (ZTS) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Bollinger Mean-Reversion
On the weekly chart, this is the strongest risk-adjusted edge we found for Zoetis (ZTS) over ~13.4 years — beating buy-and-hold by 2.0% CAGR.
Best multi-indicator combo
Going long only when all 3 agree was the strongest confluence setup we found for Zoetis (ZTS) — trailing buy-and-hold by 6.8% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Bollinger Mean-Reversion ✓ | Weekly | 10.2% | 0.88 | -12.8% | 86.7% | 15 | 2.0% |
| 2 | Fibonacci Bands ✓ | Weekly | 10.2% | 0.88 | -12.8% | 86.7% | 15 | 2.0% |
| 3 | Order-Flow Reversion ✓ | Weekly | 9.8% | 0.87 | -12.8% | 73.3% | 15 | 1.6% |
| 4 | HLC Trend | Weekly | 11.5% | 0.74 | -19.2% | 62.1% | 29 | 3.3% |
| 5 | Heikin-Ashi + EMA ✓ | Weekly | 11.4% | 0.72 | -20.6% | 59.1% | 22 | 3.2% |
| 6 | Donchian Midline | Weekly | 11.1% | 0.71 | -28.7% | 44.8% | 29 | 3.0% |
| 7 | Williams %R (28) | Weekly | 11.1% | 0.7 | -26.1% | 48.0% | 25 | 3.0% |
| 8 | RSI Trend (>50) | Weekly | 10.7% | 0.68 | -24.9% | 62.5% | 24 | 2.6% |
| 9 | SMA 30 Trend | Weekly | 10.0% | 0.68 | -22.1% | 68.2% | 22 | 1.8% |
| 10 | Volume-Weighted EMA | Weekly | 10.6% | 0.67 | -31.8% | 54.8% | 31 | 2.5% |
| 11 | CCI (30) | Weekly | 10.3% | 0.66 | -19.7% | 53.3% | 15 | 2.1% |
| 12 | EMA 30 Trend | Weekly | 9.9% | 0.65 | -29.6% | 69.2% | 26 | 1.8% |
| 13 | WMA 200 Trend | Daily | 10.1% | 0.64 | -29.3% | 36.6% | 41 | 1.9% |
| 14 | EMA 15/60 Cross | Daily | 10.2% | 0.64 | -25.0% | 46.2% | 26 | 2.0% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Zoetis (ZTS), Bollinger Mean-Reversion on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.